Found 7 matching trials
Study of DP303c Injection in Patients With Advanced Ovarian Cancer
PHASE2This study is an open-label, multicentre, phase II study to evaluate the ef...
Location
Chongqing University Cancer Hospital
DP303c in Patients With HER2-positive Advanced Breast Cancer
PHASE3This is a study of DP303c in patients with HER2-positive advanced breast ca...
Location
Multiple Locations
DP303c Versus Trastuzumab Emtansine in in Patients With HER2-positive Advanced Breast Cancer
PHASE3A Clinical Study to Evaluate the Efficacy and Safety of DP303c versus trast...
Location
Fudan University Shanghai Cancer Center
DP303c in Patients With HER2-positive Unresectable Locally Advanced, Relapsed, or Metastaticbreast Cancer
PHASE2This is a study of DP303c in patients with HER2-positive advanced breast ca...
Location
Multiple Locations
Study of DP303c Injection in Patients With Advanced or Metastatic Gastric Cancer
PHASE2This study is an open-label, multicenter, phase II study to evaluate the ef...
Location
Multiple Locations
A Study of DP303c in Patients With HER2-positive Advanced Solid Tumors
PHASE1This is a study of DP303c in patients with HER2-positive advanced solid tum...
Location
Fudan University Shanghai Cancer Center
A PhaseⅠ/Ⅱ Study of Simmitinib or Irinotecan Liposomes Combined With DP303c in Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma
PHASE1This study is divided into two parts: Cohort 1 and Cohort 2. Cohort 1 inclu...
Location
Multiple Locations